A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer Article

Industry Collaboration International Collaboration

cited authors

  • Villaruz, Liza C.; Cobo, Manuel; Syrigos, Konstantinos; Mavroudis, Dimitrios; Zhang, Wei; Kim, Jong Seok; Socinski, Mark A.

authors

Publication Date

  • October 1, 2019

webpage

published in

category

keywords

  • Carboplatin
  • Epidermal growth factor receptor (EGFR)
  • NCT00981058
  • Necitumumab
  • Squamous non-small cell lung cancer (NSCLC)
  • nab-paclitaxel

start page

  • 52

end page

  • 56

volume

  • 136